VUSB 📈 Vanguard Ultra-Short Bond - Overview
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US92203C3034 • Ultrashort Bond
VUSB: Bonds, Notes, Commercial Paper, Certificates of Deposit
The Vanguard Ultra-Short Bond ETF Shares, traded on BATS under the ticker VUSB, is designed to provide investors with a low-risk investment option by investing in a diversified portfolio of high-quality fixed income securities, with a smaller allocation to medium-quality securities. This approach aims to balance the pursuit of returns with the need to minimize exposure to credit risk. The fund's investment strategy is built around maintaining a dollar-weighted average maturity of between 0 to 2 years, which positions it as an ultrashort bond fund. This short maturity profile is intended to reduce interest rate risk, making the fund more resilient to changes in interest rates compared to funds with longer average maturities.
As an exchange-traded fund (ETF), VUSB offers the benefits of transparency, flexibility, and diversification. Under normal market conditions, the fund is expected to allocate at least 80% of its assets to fixed income securities. This significant allocation to fixed income is in line with the fund's objective of providing regular income to investors while preserving capital. The ISIN code for this ETF is US92203C3034, categorizing it under the ultrashort bond ETF category. By focusing on high-quality and, to a lesser extent, medium-quality securities, the fund aims to mitigate credit risk while still seeking to generate competitive yields in the short-term bond market.
The ultrashort bond category that VUSB belongs to is characterized by funds that invest in bonds with very short maturities, typically less than two years. This category is attractive to investors seeking low-risk investments that can provide liquidity and preserve capital, with the potential for slightly higher yields than traditional cash equivalents. The Vanguard Ultra-Short Bond ETF Shares, with its disciplined investment approach and broad diversification, is positioned to serve the needs of investors looking for a conservative fixed income strategy that can help manage interest rate risk and credit risk, while generating income from a portfolio of high-quality and medium-quality bonds.
Additional Sources for VUSB ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VUSB ETF Overview
Market Cap in USD | 4,419m |
Category | Ultrashort Bond |
TER | 0.10% |
IPO / Inception | 2021-04-06 |
VUSB ETF Ratings
Growth 5y | 63.4% |
Fundamental | - |
Dividend | 65.8% |
Rel. Strength Industry | 178 |
Analysts | - |
Fair Price Momentum | 48.01 USD |
Fair Price DCF | - |
VUSB Dividends
Dividend Yield 12m | 4.74% |
Yield on Cost 5y | 5.26% |
Annual Growth 5y | 156.12% |
Payout Consistency | 75.0% |
VUSB Growth Ratios
Growth Correlation 3m | 98% |
Growth Correlation 12m | 99.9% |
Growth Correlation 5y | 78.1% |
CAGR 5y | 2.82% |
CAGR/Mean DD 5y | 7.58 |
Sharpe Ratio 12m | 1.22 |
Alpha | 0.64 |
Beta | 0.02 |
Volatility | 0.59% |
Current Volume | 511k |
Average Volume 20d | 808.7k |
As of December 27, 2024, the stock is trading at USD 49.55 with a total of 511,000 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +0.45%, over three months by +0.90% and over the past year by +5.73%.
Yes. Based on ValueRay Analyses, Vanguard Ultra-Short Bond (BATS:VUSB) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 63.43 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VUSB as of December 2024 is 48.01. This means that VUSB is currently overvalued and has a potential downside of -3.11%.
Vanguard Ultra-Short Bond has no consensus analysts rating.
According to ValueRays Forecast Model, VUSB Vanguard Ultra-Short Bond will be worth about 51.9 in December 2025. The stock is currently trading at 49.55. This means that the stock has a potential upside of +4.64%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 51.9 | 4.6% |